Our Practice


The rheumatologists at RDC provide state-of-the-art diagnosis and treatment for diseases that affect the body’s connective tissue. RDC rheumatologists treat more the 100 types of arthritis, including common diseases such as rheumatoid arthritis and osteoarthritis and rare diseases such as relapsing polychondritis and ANCA associated vasculitis. Additionally, physicians offer vasculitis treatment, consultations and continued care for patients with regional muscular skeletal disorders such as shoulder pain, hip pain, and knee pain. Preoperative evaluation and recommendations for patients considering joint replacement and arthritis-related reconstructive surgeries are also provided.


Our highly trained and skilled team covers your complete care.




RDCRC performs Phase II through IV clinical trials in Rheumatology. Our main focus is the field of Rheumatology clinical trials—either ongoing or anticipated in the near future. This includes trials in therapeutic areas such as Rheumatoid Arthritis, Osteoarthritis, SLE, Gout and toxicities of various arthritis medications. Our Internal Medicine and Family Practice area of expertise include Hypertension, Type II Diabetes Mellitus, Dyslipidemia, Myocardial Infarction, Insomnia, Osteoporosis and many others.


  • Complete Rheumatology Center
  • 2 large IV infusion therapy rooms (14 chairs/pumps)
  • Clinical laboratory and cryogenic freezer
  • Secure, stable-temperature drug storage
  • CRA work areas with fax, internet & copier access
  • Secure records retention
  • Complete imaging center
  • Large, computerized patient database
  • Full-time GCP-trained-and-tested CRCs
  • 12-lead EKG machine / EKG technician


Because RDCRC does not conduct any of its activities at a hospital or medical school, we can use any central IRB selected by the Sponsor or CRO. We have worked effectively and efficiently with many different central IRBs. In addition, we have developed a rapid-response system to quickly and accurately complete all regulatory and contract requirements for study start up. RDCH, is often among the first sites to enroll study subjects in clinical trials. Pharmaceutical companies and CROs find RDCH to be one of their most responsive sites.